204 related articles for article (PubMed ID: 37587773)
1. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
[TBL] [Abstract][Full Text] [Related]
2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma.
Liu MR; Shi C; Song QY; Kang MJ; Jiang X; Liu H; Pei DS
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37695069
[TBL] [Abstract][Full Text] [Related]
4. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
6. RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
Xie W; Wang J; Tian S; Zhao H; Cao L; Liang Z; Yang J; Zhao Y; Wang B; Jiang F; Ma J
Oncogene; 2024 May; 43(19):1463-1475. PubMed ID: 38514855
[TBL] [Abstract][Full Text] [Related]
7. TRIM21 ubiquitylates GPX4 and promotes ferroptosis to aggravate ischemia/reperfusion-induced acute kidney injury.
Sun X; Huang N; Li P; Dong X; Yang J; Zhang X; Zong WX; Gao S; Xin H
Life Sci; 2023 May; 321():121608. PubMed ID: 36958437
[TBL] [Abstract][Full Text] [Related]
8. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
[TBL] [Abstract][Full Text] [Related]
9. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
Lee J; Roh JL
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
[TBL] [Abstract][Full Text] [Related]
10. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury.
Ma Y; Huang L; Zhang Z; Yang P; Chen Q; Zeng X; Tan F; Wang C; Ruan X; Liao X
Genes Dis; 2024 Jan; 11(1):449-463. PubMed ID: 37588197
[TBL] [Abstract][Full Text] [Related]
11. Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin.
Hou K; Shen J; Yan J; Zhai C; Zhang J; Pan JA; Zhang Y; Jiang Y; Wang Y; Lin RZ; Cong H; Gao S; Zong WX
EBioMedicine; 2021 Jul; 69():103456. PubMed ID: 34233258
[TBL] [Abstract][Full Text] [Related]
12. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
Apoptosis; 2024 Apr; ():. PubMed ID: 38615304
[TBL] [Abstract][Full Text] [Related]
13. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
[TBL] [Abstract][Full Text] [Related]
15. Phase separation of FSP1 promotes ferroptosis.
Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
[TBL] [Abstract][Full Text] [Related]
16. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.
Kim JW; Kim MJ; Han TH; Lee JY; Kim S; Kim H; Oh KJ; Kim WK; Han BS; Bae KH; Ban HS; Bae SH; Lee SC; Lee H; Lee EW
Cell Death Dis; 2023 Aug; 14(8):567. PubMed ID: 37633973
[TBL] [Abstract][Full Text] [Related]
17. HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.
Yuan J; Lv T; Yang J; Wu Z; Yan L; Yang J; Shi Y
Redox Biol; 2022 Dec; 58():102546. PubMed ID: 36423520
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Induces Ferroptosis in A549 CD133
Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M
Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092
[TBL] [Abstract][Full Text] [Related]
19. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
[TBL] [Abstract][Full Text] [Related]
20. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis.
Pan JA; Sun Y; Jiang YP; Bott AJ; Jaber N; Dou Z; Yang B; Chen JS; Catanzaro JM; Du C; Ding WX; Diaz-Meco MT; Moscat J; Ozato K; Lin RZ; Zong WX
Mol Cell; 2016 Mar; 61(5):720-733. PubMed ID: 26942676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
